Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2004
03/25/2004WO2004024954A1 Method for screening of a lipase having improved enzymatic activity using yeast surface display vector and the lipase
03/25/2004WO2004024953A1 Method for preparation of cdna tags for identifying expressed genes and method for analysis of gene expression
03/25/2004WO2004024952A1 Method of diagnosing ovarian endometriosis
03/25/2004WO2004024951A1 Methods to quantify and genotype dna based on the enzyme kinetics analysis of pcr
03/25/2004WO2004024950A1 Method for the selection of nucleic acid ligands
03/25/2004WO2004024949A2 Method of rapid detection of mutations and nucleotide polymorphisms using chemometrics
03/25/2004WO2004024948A1 Use of an analysing substance for detecting an explosive
03/25/2004WO2004024947A1 Actn3 genotype screen for athletic performance
03/25/2004WO2004024946A1 Homogeneous fluorescence assay for kinases, phosphatases, and phosphodiesterases
03/25/2004WO2004024945A2 Method for the non-invasive detection of microorganisms in a closed container
03/25/2004WO2004024944A2 Method and nucleotide sequences for the detection and identification of micro-organisms in a complex mixture or water
03/25/2004WO2004024942A1 Amp-activated protein kinase (ampk) inhibitor screening assay
03/25/2004WO2004024941A2 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
03/25/2004WO2004024937A2 Virulence-associated nucleic acids and proteins and uses thereof
03/25/2004WO2004024920A1 Preventives/remedies for neurodegenerative diseases
03/25/2004WO2004024919A1 Non-sequence complementary antiviral oligonucleotides
03/25/2004WO2004024914A1 2’,5’-oligoadenylate phosphodiesterase
03/25/2004WO2004024906A1 Nucleoside triphosphate diphosphohydrolase (ntpdase 8) and uses thereof
03/25/2004WO2004024904A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
03/25/2004WO2004024903A1 Method of separating epithelial cells from a human or animal urine sample
03/25/2004WO2004024893A2 Nell-1 enhanced bone mineralization
03/25/2004WO2004024892A2 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis
03/25/2004WO2004024886A2 Microarray synthesis and assembly of gene-length polynucleotides
03/25/2004WO2004024884A2 Syts as modifiers of the p21 pathway and methods of use
03/25/2004WO2004024883A2 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE
03/25/2004WO2004024882A2 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
03/25/2004WO2004024880A2 AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
03/25/2004WO2004024879A2 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
03/25/2004WO2004024875A2 Mammalian megakaryocyte progenitor cell
03/25/2004WO2004024864A2 Rna-cleaving dna enzymes with altered regio- or enantioselectivity
03/25/2004WO2004024760A1 Novel protein and dna thereof
03/25/2004WO2004024749A2 Thermostable reverse transcriptases and uses thereof
03/25/2004WO2004024744A2 Production of glycosylated macrolides in e. coli
03/25/2004WO2004024283A2 Apparatus and method for preparative scale purification of nucleic acids
03/25/2004WO2004024097A2 Compositions and methods for the treatment of immune related diseases
03/25/2004WO2004024087A2 Methods of diagnosing and treating hyperproliferative disorders
03/25/2004WO2004024084A2 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling
03/25/2004WO2004024082A2 Highly specific modulators of gtpases for target validation
03/25/2004WO2004024077A2 Novel composition and methods for the treatment of psoriasis
03/25/2004WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases
03/25/2004WO2004024068A2 Novel composition and methods for the treatment of immune related diseases
03/25/2004WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor
03/25/2004WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor
03/25/2004WO2004024026A2 Method and device for monitoring platelet function
03/25/2004WO2004023973A2 Molecules for diagnostics and therapeutics
03/25/2004WO2004023869A1 Use of plag or plag-inhibitors to diagnose and/or treat disease
03/25/2004WO2004023867A2 Transgenic cancer models in fish
03/25/2004WO2004013319A3 Regulation of human esterase
03/25/2004WO2004007722A3 Transgenic animal expressing alzheimer’s tau protein
03/25/2004WO2004007718A3 Rna-interference by single-stranded rna molecules
03/25/2004WO2004005547A3 Method for identifying hypersensitive site consensus sequences
03/25/2004WO2004004647A3 Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes
03/25/2004WO2003107008A3 DIAGNOSTIC POLYMORPHISM OF 11ß-HYDROXYSTEROID DEHYDROGENASE USEFUL FOR IDENTIFYING RISK OF DEVELOPING ALZHEIMER'S DISEASE
03/25/2004WO2003103676A3 Method of treating cancer using kinase inhibitors
03/25/2004WO2003102124A3 Method and apparatus for measuring nitric oxide production and oxygen consumption in cultures of adherent cells
03/25/2004WO2003100077A3 Label-free detection of single nucleotide polymorphisms using surface plasmon resonance imaging
03/25/2004WO2003100001A3 Claudin polypeptides, polynucleotides, and methods of making and use thereof
03/25/2004WO2003093406A3 Microfermentors for rapid screening and analysis of biochemical processes
03/25/2004WO2003090685A3 Methods for stimulating tlr/irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses
03/25/2004WO2003085375A3 Hcv antiviral and cytotoxicity drug screening assay
03/25/2004WO2003085133A3 Novel fissr-pcr primers and method of genotyping diverse genomes of plant and animal systems including rice varieties
03/25/2004WO2003083481A3 Luminescent, spheroid, non-autofluorescent silica gel particles having variable emission intensities and frequencies
03/25/2004WO2003083098A3 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy
03/25/2004WO2003083051A3 Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples
03/25/2004WO2003082903A3 Hybrid phosphoinositide phospholipids: compositions and uses
03/25/2004WO2003080100A3 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 63 (gpr63)
03/25/2004WO2003078045A3 Microcapillary hybridization chamber
03/25/2004WO2003077844A3 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria
03/25/2004WO2003076892A9 Device and methods for measuring the response of at least one cell to a medium
03/25/2004WO2003075747A3 Contrast agents for magnetic resonance imaging and methods related thereto
03/25/2004WO2003074724A3 Polynomial amplification of nucleic acids
03/25/2004WO2003074674A3 MSRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
03/25/2004WO2003072804A3 Nanostructures containing pilin protein
03/25/2004WO2003072798A3 Method for generating amplified rna
03/25/2004WO2003069338A3 Analysis of vital substances
03/25/2004WO2003068712A3 Novel method for production of dna biochips and applications thereof
03/25/2004WO2003066896A3 Method for the detection of mutations
03/25/2004WO2003066890A3 Method for determining the methylation pattern of dna
03/25/2004WO2003059518A3 An assay device and method for chemical or biological screening
03/25/2004WO2003057910A3 Use of silica material in an amplification reaction
03/25/2004WO2003057902A3 A method to assess quorum sensing potential of microbial communities
03/25/2004WO2003056340A3 Fadd proteins, phosphorylated p38-mapk and fasl as tumour markers
03/25/2004WO2003055443A3 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
03/25/2004WO2003054227A3 Method for the quantitative determination of gene expression
03/25/2004WO2003054156A3 Novel g proein-coupled receptor, gave7
03/25/2004WO2003052134A3 Oligonucleotides comprising intercalator pseudonucleotide(s) for detection of nucleic acids and mutants hereof
03/25/2004WO2003051923A3 Novel g-protein coupled receptors and dna sequences thereof
03/25/2004WO2003046578A3 Method for the assessment and prognosis of sarcoidosis
03/25/2004WO2003042353A9 Methods for detection of a target nucleic acid by capture using multi-subunit probes
03/25/2004WO2003040296A3 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
03/25/2004WO2003039475A3 Methods of identifying and using modulators of fractalkine receptor
03/25/2004WO2003038122A3 Asymmetrical probes
03/25/2004WO2003038042A3 Molecular detection systems utilizing reiterative oligonucleotide synthesis
03/25/2004WO2003033680A3 Kinases and phosphatases
03/25/2004WO2003025128A3 Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets
03/25/2004WO2003020963A3 Proteins in type 2 diabetes
03/25/2004WO2003020887A3 Gene identification
03/25/2004WO2003018835A3 Method for rapid detection of haplotypes
03/25/2004WO2003014745A3 Method for identifying anti-inflammatory drugs
03/25/2004WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use